Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Small-Cell Lung Cancer
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
U.S. Food and Drug Administration Approves Opdivo®(nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer
Bristol-Myers Squibb
PR-M09-18-NI-065
Sep 21, 2018
Collaboration
Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer
Amgen
PR-M06-18-NI-028
Jun 08, 2018
